Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Choosing medications wisely: Is it time to address paediatric polypharmacy?

Bogler O, Roth D, Feinstein J, Strzelecki M, Seto W, Cohen E.

Paediatr Child Health. 2019 Aug;24(5):303-305. doi: 10.1093/pch/pxy188. Epub 2019 Jan 5.

PMID:
31379430
2.

Fully Automatic Treatment Planning for External-Beam Radiation Therapy of Locally Advanced Cervical Cancer: A Tool for Low-Resource Clinics.

Kisling K, Zhang L, Simonds H, Fakie N, Yang J, McCarroll R, Balter P, Burger H, Bogler O, Howell R, Schmeler K, Mejia M, Beadle BM, Jhingran A, Court L.

J Glob Oncol. 2019 Jan;5:1-9. doi: 10.1200/JGO.18.00107.

3.

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System.

Court LE, Kisling K, McCarroll R, Zhang L, Yang J, Simonds H, du Toit M, Trauernicht C, Burger H, Parkes J, Mejia M, Bojador M, Balter P, Branco D, Steinmann A, Baltz G, Gay S, Anderson B, Cardenas C, Jhingran A, Shaitelman S, Bogler O, Schmeller K, Followill D, Howell R, Nelson C, Peterson C, Beadle B.

J Vis Exp. 2018 Apr 11;(134). doi: 10.3791/57411.

4.

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH.

Ann Oncol. 2018 Feb 1;29(2):405-417. doi: 10.1093/annonc/mdx651.

5.

m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.

Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, Chen Y, Sulman EP, Xie K, Bögler O, Majumder S, He C, Huang S.

Cancer Cell. 2017 Apr 10;31(4):591-606.e6. doi: 10.1016/j.ccell.2017.02.013. Epub 2017 Mar 23.

6.

Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.

Shingu T, Holmes L, Henry V, Wang Q, Latha K, Gururaj AE, Gibson LA, Doucette T, Lang FF, Rao G, Yuan L, Sulman EP, Farrell NP, Priebe W, Hess KR, Wang YA, Hu J, Bögler O.

J Transl Med. 2016 Feb 9;14:46. doi: 10.1186/s12967-016-0803-2.

7.

A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.

Bagheri-Yarmand R, Sinha KM, Gururaj AE, Ahmed Z, Rizvi YQ, Huang SC, Ladbury JE, Bogler O, Williams MD, Cote GJ, Gagel RF.

J Biol Chem. 2015 May 1;290(18):11749-61. doi: 10.1074/jbc.M114.619833. Epub 2015 Mar 20.

8.

Radiation-induced autophagy contributes to cell death and induces apoptosis partly in malignant glioma cells.

Jo GH, Bögler O, Chwae YJ, Yoo H, Lee SH, Park JB, Kim YJ, Kim JH, Gwak HS.

Cancer Res Treat. 2015 Apr;47(2):221-41. doi: 10.4143/crt.2013.159. Epub 2014 Aug 29.

9.

Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.

Gressot LV, Doucette TA, Yang Y, Fuller GN, Heimberger AB, Bögler O, Rao A, Latha K, Rao G.

Int J Cancer. 2015 May 1;136(9):2047-54. doi: 10.1002/ijc.29264. Epub 2014 Oct 23.

10.

Telemedicine and telesurgery in cancer care: inaugural conference at MD Anderson Cancer Center.

Satcher RL, Bogler O, Hyle L, Lee A, Simmons A, Williams R, Hawk E, Matin S, Brewster AM.

J Surg Oncol. 2014 Sep;110(4):353-9. doi: 10.1002/jso.23652. Epub 2014 May 29. Review.

PMID:
24889208
11.

Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis.

Ray M, Goldstein S, Zhou S, Potamousis K, Sarkar D, Newton MA, Esterberg E, Kendziorski C, Bogler O, Schwartz DC.

BMC Genomics. 2013 Jul 26;14:505. doi: 10.1186/1471-2164-14-505.

12.

The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.

Promkan M, Dakeng S, Chakrabarty S, Bögler O, Patmasiriwat P.

PLoS One. 2013;8(2):e55732. doi: 10.1371/journal.pone.0055732. Epub 2013 Feb 5.

13.

Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.

Garnett J, Chumbalkar V, Vaillant B, Gururaj AE, Hill KS, Latha K, Yao J, Priebe W, Colman H, Elferink LA, Bogler O.

Neoplasia. 2013 Jan;15(1):73-84.

14.

Access to the nucleus and functional association with c-Myc is required for the full oncogenic potential of ΔEGFR/EGFRvIII.

Gururaj AE, Gibson L, Panchabhai S, Bai M, Manyam G, Lu Y, Latha K, Rojas ML, Hwang Y, Liang S, Bogler O.

J Biol Chem. 2013 Feb 1;288(5):3428-38. doi: 10.1074/jbc.M112.399352. Epub 2012 Dec 17.

15.

Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.

Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K, Priebe W, Bögler O, Heimberger AB, Rao G.

Neuro Oncol. 2012 Sep;14(9):1136-45. doi: 10.1093/neuonc/nos139. Epub 2012 Jun 29.

16.

Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.

Latha K, Li M, Chumbalkar V, Gururaj A, Hwang Y, Dakeng S, Sawaya R, Aldape K, Cavenee WK, Bogler O, Furnari FB.

Int J Cancer. 2013 Feb 1;132(3):509-20. doi: 10.1002/ijc.27690. Epub 2012 Jul 9. Erratum in: Int J Cancer. 2015 Sep 15;137(6):E10-1.

17.

A simple guide screw method for intracranial xenograft studies in mice.

Donoghue JF, Bogler O, Johns TG.

J Vis Exp. 2011 Sep 26;(55). pii: 3157. doi: 10.3791/3157.

18.

Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma.

Zhu H, Li JT, Zheng F, Martin E, Kots AY, Krumenacker JS, Choi BK, McCutcheon IE, Weisbrodt N, Bögler O, Murad F, Bian K.

Mol Pharmacol. 2011 Dec;80(6):1076-84. doi: 10.1124/mol.111.073585. Epub 2011 Sep 9.

19.

Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.

Dakeng S, Duangmano S, Jiratchariyakul W, U-Pratya Y, Bögler O, Patmasiriwat P.

J Cell Biochem. 2012 Jan;113(1):49-60. doi: 10.1002/jcb.23326.

20.

Forced dimerization increases the activity of ΔEGFR/EGFRvIII and enhances its oncogenicity.

Hwang Y, Chumbalkar V, Latha K, Bogler O.

Mol Cancer Res. 2011 Sep;9(9):1199-208. doi: 10.1158/1541-7786.MCR-11-0229. Epub 2011 Jul 20.

21.

Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR.

Chumbalkar V, Latha K, Hwang Y, Maywald R, Hawley L, Sawaya R, Diao L, Baggerly K, Cavenee WK, Furnari FB, Bogler O.

J Proteome Res. 2011 Mar 4;10(3):1343-52. doi: 10.1021/pr101075e. Epub 2011 Feb 14.

22.

Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.

Staquicini FI, Ozawa MG, Moya CA, Driessen WH, Barbu EM, Nishimori H, Soghomonyan S, Flores LG 2nd, Liang X, Paolillo V, Alauddin MM, Basilion JP, Furnari FB, Bogler O, Lang FF, Aldape KD, Fuller GN, Höök M, Gelovani JG, Sidman RL, Cavenee WK, Pasqualini R, Arap W.

J Clin Invest. 2011 Jan;121(1):161-73. doi: 10.1172/JCI44798. Epub 2010 Dec 22.

23.

The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells.

Shingu T, Chumbalkar VC, Gwak HS, Fujiwara K, Kondo S, Farrell NP, Bogler O.

Neuro Oncol. 2010 Dec;12(12):1269-77. doi: 10.1093/neuonc/noq095. Epub 2010 Aug 16.

24.

CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice.

Shimokawa N, Haglund K, Hölter SM, Grabbe C, Kirkin V, Koibuchi N, Schultz C, Rozman J, Hoeller D, Qiu CH, Londoño MB, Ikezawa J, Jedlicka P, Stein B, Schwarzacher SW, Wolfer DP, Ehrhardt N, Heuchel R, Nezis I, Brech A, Schmidt MHH, Fuchs H, Gailus-Durner V, Klingenspor M, Bogler O, Wurst W, Deller T, de Angelis MH, Dikic I.

EMBO J. 2010 Jul 21;29(14):2421-32. doi: 10.1038/emboj.2010.120. Epub 2010 Jun 15.

25.

Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.

Gwak HS, Shingu T, Chumbalkar V, Hwang YH, DeJournett R, Latha K, Koul D, Alfred Yung WK, Powis G, Farrell NP, Bögler O.

Int J Cancer. 2011 Feb 15;128(4):787-96. doi: 10.1002/ijc.25394.

26.

Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.

Yong RL, Shinojima N, Fueyo J, Gumin J, Vecil GG, Marini FC, Bogler O, Andreeff M, Lang FF.

Cancer Res. 2009 Dec 1;69(23):8932-40. doi: 10.1158/0008-5472.CAN-08-3873. Epub 2009 Nov 17.

27.

Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity.

Shingu T, Fujiwara K, Bögler O, Akiyama Y, Moritake K, Shinojima N, Tamada Y, Yokoyama T, Kondo S.

Autophagy. 2009 May;5(4):537-9. Epub 2009 May 13.

PMID:
19270491
28.

Exploratory analysis of the copy number alterations in glioblastoma multiforme.

Freire P, Vilela M, Deus H, Kim YW, Koul D, Colman H, Aldape KD, Bogler O, Yung WK, Coombes K, Mills GB, Vasconcelos AT, Almeida JS.

PLoS One. 2008;3(12):e4076. doi: 10.1371/journal.pone.0004076. Epub 2008 Dec 30.

29.

Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells.

Shingu T, Fujiwara K, Bögler O, Akiyama Y, Moritake K, Shinojima N, Tamada Y, Yokoyama T, Kondo S.

Int J Cancer. 2009 Mar 1;124(5):1060-71. doi: 10.1002/ijc.24030.

30.

Proteomics: the new frontier also for brain tumor research.

Chumbalkar V, Sawaya R, Bogler O.

Curr Probl Cancer. 2008 May-Jun;32(3):143-54. doi: 10.1016/j.currproblcancer.2008.02.005. Review. No abstract available.

PMID:
18501776
31.

Biomarkers and cancer stem cells in primary brain tumors. Foreword.

Bogler O, Sawaya R.

Curr Probl Cancer. 2008 May-Jun;32(3):95-6. doi: 10.1016/j.currproblcancer.2008.02.002. No abstract available.

PMID:
18501773
32.

Isolation and purification of primary oligodendrocyte precursors.

Bögler O.

Curr Protoc Neurosci. 2001 May;Chapter 3:Unit 3.4. doi: 10.1002/0471142301.ns0304s00.

PMID:
18428468
33.

Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3.

Aoki H, Kondo Y, Aldape K, Yamamoto A, Iwado E, Yokoyama T, Hollingsworth EF, Kobayashi R, Hess K, Shinojima N, Shingu T, Tamada Y, Zhang L, Conrad C, Bogler O, Mills G, Sawaya R, Kondo S.

Autophagy. 2008 May;4(4):467-75. Epub 2008 Feb 4.

PMID:
18259115
34.

Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY.

Oncogene. 2007 Aug 16;26(38):5577-86. Epub 2007 Mar 19.

35.

Proteomic comparison of oligodendrogliomas with and without 1pLOH.

Okamoto H, Li J, Gläsker S, Vortmeyer AO, Jaffe H, Robison RA, Bogler O, Mikkelsen T, Lubensky IA, Oldfield EH, Zhuang Z.

Cancer Biol Ther. 2007 Mar;6(3):391-6. Epub 2007 Mar 20.

PMID:
17264672
36.

Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins.

Dejournett RE, Kobayashi R, Pan S, Wu C, Etkin LD, Clark RB, Bögler O, Kuang J.

Biochem J. 2007 Jan 15;401(2):521-31.

37.

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.

Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M.

Clin Cancer Res. 2006 Aug 1;12(15):4671-7.

38.

Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma.

Billecke C, Finniss S, Tahash L, Miller C, Mikkelsen T, Farrell NP, Bögler O.

Neuro Oncol. 2006 Jul;8(3):215-26. Epub 2006 May 24.

39.

Angiogenesis and apoptosis in glioma: two arenas for promising new therapies.

Bögler O, Mikkelsen T.

J Cell Biochem. 2005 Sep 1;96(1):16-24. Review.

PMID:
16052525
40.

Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles.

Billecke C, Malik I, Movsisyan A, Sulghani S, Sharif A, Mikkelsen T, Farrell NP, Bögler O.

Mol Cell Proteomics. 2006 Jan;5(1):35-42. Epub 2005 Jun 10.

41.

Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities.

Schmidt MHH, Dikic I, Bögler O.

J Biol Chem. 2005 Feb 4;280(5):3414-25. Epub 2004 Nov 22.

42.

Studying protein isoforms of the adaptor SETA/CIN85/Ruk with monoclonal antibodies.

Finniss S, Movsisyan A, Billecke C, Schmidt M, Randazzo L, Chen B, Bögler O.

Biochem Biophys Res Commun. 2004 Dec 3;325(1):174-82.

PMID:
15522216
43.

Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.

Schmidt MHH, Hoeller D, Yu J, Furnari FB, Cavenee WK, Dikic I, Bögler O.

Mol Cell Biol. 2004 Oct;24(20):8981-93.

44.

Proliferation marker pKi-67 occurs in different isoforms with various cellular effects.

Schmidt MH, Broll R, Bruch HP, Finniss S, Bögler O, Duchrow M.

J Cell Biochem. 2004 Apr 15;91(6):1280-92.

PMID:
15048881
45.

Constitutive EGFR signaling confers a motile phenotype to neural stem cells.

Boockvar JA, Kapitonov D, Kapoor G, Schouten J, Counelis GJ, Bogler O, Snyder EY, McIntosh TK, O'Rourke DM.

Mol Cell Neurosci. 2003 Dec;24(4):1116-30.

PMID:
14697673
46.

p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding.

Peterson EJ, Bögler O, Taylor SM.

Cancer Res. 2003 Oct 15;63(20):6579-82.

47.

Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.

Mihaila D, Jankowski M, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA; NABTT CNS Consortium.

Clin Cancer Res. 2003 Oct 1;9(12):4443-51.

48.

Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.

Mihaila D, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA; NABTT CNS Consortium.

Clin Cancer Res. 2003 Oct 1;9(12):4435-42.

49.

Angiogenesis in glioma: molecular mechanisms and roadblocks to translation.

Bögler O, Mikkelsen T.

Cancer J. 2003 May-Jun;9(3):205-13. Review.

PMID:
12952305
50.

International Hermelin Brain Tumor Center Symposium on Apoptosis.

Bögler O, Weller M.

Cell Death Differ. 2003 Sep;10(9):1112-5. No abstract available.

Supplemental Content

Loading ...
Support Center